1. U.S. Food and Drug Administration. Aspartame: Commissioner’s Final Decision. Fed Register. 1981;46:38283.
2. U.S. Food and Drug Administration. Inactive Ingredient Search for Approved Drug Products. 2023. Available from: https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=BasicSearch.page.
3. National Intitutes of Health, Office of Dietary Supplements,. Dietary Supplement Label Database (DSLD). 2023. Available from: https://dsld.od.nih.gov/search/aspartame/bWFya2V0X3N0YXR1cz1vbl9tYXJrZXQvZW50cnlfZGF0ZT0yMDExLDIwMjMvc29ydD1tYXRjaC9wYWdlX3NpemU9MjAv.
4. Riboli E, Beland FA, Lachenmeier DW, Marques MM, Phillips DH, Schernhammer E, et al. Carcinogenicity of aspartame, methyleugenol, and isoeugenol. Lancet Oncol. 2023;24:848–50.
5. U.S. Food and Drug Administration. Aspartame and Other Sweeteners in Food. 2023. Available from: https://www.fda.gov/food/food-additives-petitions/aspartame-and-other-sweeteners-food.